Santella Advances to Stage 2 of Venture Kick
Santella is proud to announce that it has successfully passed Stage 2 of the Venture Kick program. This achievement confirms the potential of our innovative
We develop innovative probiotic live vaccines to protect poultry against diseases. Our solution reduces the need for antibiotics, supporting healthier flocks and safer food systems. Driven by science and sustainability, we’re shaping the future of animal health.
Poultry producers face mounting pressure to reduce antibiotic use while keeping flocks healthy. This challenge creates a powerful opportunity for innovation in animal health.
Antibiotic resistance is one of the biggest threats facing both animal and human health. In poultry farming, avian pathogenic E. coli infections lead to major economic losses, while excessive reliance on antibiotics raises food safety concerns and accelerates antimicrobial resistance.
Global demand for antibiotic-free poultry products is rising by double each year.
The poultry industry is actively seeking sustainable, scalable alternatives that protect flock health while meeting growing consumer demand for antibiotic-free products. This shift opens the door for innovative solutions that improve profitability for producers and promote safer, more responsible farming practices.
Santella offers a sustainable and innovative solution: a targeted probiotic live vaccine specifically designed to combat avian pathogenic E. coli in poultry. The vaccine boosts the immune response and enhances gut health, ultimately reducing the need for antibiotics. The global poultry industry seeks alternatives to antibiotics also driven by consumer demand.
Our vaccine represents a scalable, cost-effective solution that can be integrated into existing poultry farming practices, with strong appeal to producers aiming to improve flock health and profitability.
Our innovative probiotic live vaccine is designed to combat avian pathogenic E. coli, strengthening flock immunity and reducing reliance on antibiotics.
Santella’s targeted vaccine boosts the natural immune response and supports gut health, offering poultry producers a sustainable, scalable, and cost-effective alternative to antibiotics. Easy to integrate into existing farming practices, it helps improve bird welfare while supporting industry profitability.
We’ve developed a targeted, science-driven vaccine that works naturally with the bird’s microbiome to strengthen immunity from within. By harnessing the power of probiotics, our solution not only protects against avian pathogenic E. coli but also improves overall gut health. This approach reduces the dependence on antibiotics, supports animal welfare, and promotes long-term sustainability across the poultry industry.
Specially bio-engineered probiotic vaccine delivers protection directly to the gut.
Strengthens natural defenses, reducing the risk of E. coli infections.
Preclinically tested in over 300 animals, our vaccine candidate has shown strong efficacy. Built on a versatile platform, the technology can be adapted to protect other livestock species and target a variety of diseases.
Our dedicated team combines expertise in science, innovation, and entrepreneurship and is united by a shared mission: to advance sustainable poultry health through cutting-edge biotechnology.
An accomplished professional with expertise in microbiology and immunology, complemented by a solid foundation in business administration. Brings valuable experience in the pharmaceutical industry, bridging science and business to drive impactful results.
Completing the team are scientists, innovators, and industry leaders united by a shared mission: to advance sustainable poultry health through cutting-edge biotechnology.
Has a strong track record in entrepreneurship and innovation. As an Innosuisse business coach, she brings strategic vision and business expertise to drive the team’s vision forward.
An industry expert leveraging his exceptional network and reputation to guide strategic decisions in poultry health biotechnology.
Has deep expertise in microbiome research and helps drive the scientific foundation of the team’s work in sustainable poultry health.
A regulatory and development specialist with extensive experience in biotech and animal health, supporting the team in navigating regulations and advancing projects from development to market.
Reducing reliance on antibiotics to support safer food systems and protect the environment well aligned with the UN's SDGs.
Promoting healthier flocks through natural immunity and improved well-being.
Expanding our technology to new applications, driving innovation across the animal health industry.
Santella is proud to announce that it has successfully passed Stage 2 of the Venture Kick program. This achievement confirms the potential of our innovative
Santella has successfully submitted a Patent Cooperation Treaty (PCT) application covering its innovative vaccine candidate. The application marks an important milestone in strengthening the company’s
Santella has secured a research collaboration within an Innosuisse Innovation Project with the Biotechnology Group at the University of Applied Sciences HES-SO in Sion. The
Santella has secured a research collaboration within an Innosuisse Innovation Project with the Biotechnology Group at the University of Applied Sciences HES-SO in Sion. The
Santella has successfully submitted a Patent Cooperation Treaty (PCT) application covering its innovative vaccine candidate. The application marks an important milestone in strengthening the company’s
Have a question, partnership idea, or pilot in mind? Send us a note or connect on LinkedIn—our team will get back within 2 business days.
